Related Experiment Videos

Improved results of living-related liver transplantation with routine application in a pediatric program

J C Emond1, T G Heffron, E O Kortz

  • 1Department of Surgery, University of Chicago, Illinois.

Transplantation
|April 1, 1993
PubMed

Insights

Living related liver transplantation (LRT) significantly increases donor organ availability for pediatric patients, improving survival rates. This approach allows more children to receive transplants at the optimal time, expanding treatment options.

Area of Science:

  • Hepatology
  • Transplantation Surgery
  • Pediatric Gastroenterology

Background:

  • Donor organ shortage is a critical issue in pediatric liver transplantation.
  • Living related liver transplantation (LRT) was developed to address this shortage.
  • Initial LRT outcomes showed promising patient and graft survival rates.

Purpose of the Study:

  • To present the experience with 45 consecutive liver transplants, evaluating the role and outcomes of LRT.
  • To assess the impact of LRT on graft availability and patient survival in a pediatric center.
  • To determine the feasibility of expanding LRT for conditions like fulminant hepatic failure.

Main Methods:

  • Retrospective analysis of 45 liver transplants performed between April 1991 and April 1992 in 41 children.
  • Categorization of transplants into cadaveric donor and living related donor grafts.
  • Analysis of patient demographics, underlying liver diseases, UNOS status, and outcomes (survival, graft loss).

Main Results:

  • Overall patient survival was 90% across 45 transplants.
  • Living related liver transplantation (LRT) accounted for 40% of grafts, with a patient survival of 94%.
  • Cadaveric grafts had 88% patient survival and 74% graft survival, with many recipients on urgent UNOS status.

Conclusions:

  • Living related liver transplantation (LRT) enhances graft availability, enabling timely transplants for pediatric patients.
  • The benefits of increased graft availability with LRT outweigh concerns, supporting its routine use.
  • LRT is a viable option for fulminant hepatic failure and may be extended to adult recipients.

Related Concept Videos